COVID-19 vaccines: immunology, regulation and clinical management

Anita K. Simonds, Rosemary J. Boyton

Source: Eur Respir Monogr 2021; 94: 244-260
Journal Issue: COVID-19

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anita K. Simonds, Rosemary J. Boyton. COVID-19 vaccines: immunology, regulation and clinical management. Eur Respir Monogr 2021; 94: 244-260

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
M. tuberculosis: immunology and vaccination
Source: Eur Respir J 2001; 17: 537-557
Year: 2001



From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013


Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020



Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007



New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Latest insights and challenges in tuberculosis vaccine development
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019


The role of virus infections in asthma: immune responses and future possibilities
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
Source: Virtual Congress 2020 – New developments in pandemic medicine
Year: 2020


New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities
Source: Eur Respir Rev 2009; 18: 198-212
Year: 2009


From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017


Characterisation of clinical phenotypes is mandatory for the development of new drugs
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021


Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020

What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018


The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018



Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR)
Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions
Year: 2021